Rande Is . . . HOME Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rande Is who wrote (28522)	6/26/2000 7:20:00 PM
From: Tradelite	Read Replies (2) of 57584

Re: investing in biotechs.... Just before disappearing all afternoon for business appointments, I listened to an on-air dissertation by a biology/biotech expert who later in life transformed himself into a private portfolio manager with Capital Securities Management in McLean, VA. If the "smart money" is advising the "dumb money" along the same lines as this guy, the dummies are being told that true financial/investment/medical results from genome/biotech breakthroughs are a full decade away. Furthermore, according to him, the primary beneficiaries of the genome thing will be the pharma companies, and meanwhile, the dummies should put their money in the companies that supply the "picks and shovels" to the genome endeavor. Gene Logic and PE Biosystems are two of his top picks. Good luck to the swift who are making money in this area. I'm much too slow and and frequently absent from the computer to play this volatile field. :(

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next